Butibufen enteric-coated vs non-enteric-coated microcapsules: pharmacokinetics and gastrointestinal blood loss effect relationships in healthy volunteers.
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D002214:Capsules; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D007700:Kinetics; D010654:Phenylbutyrates / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D013608:Tablets, Enteric-Coated
D000893:Anti-Inflammatory Agents; D002214:Capsules; D010654:Phenylbutyrates; D013608:Tablets, Enteric-Coated; C012797:butibufen